The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society

@article{Shifren2005TheRO,
  title={The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society},
  author={Jan L. Shifren and Susan R. Davis and Lorraine Dennerstein and Julia R. Heiman and Rogerio A. Lobo and James A Simon},
  journal={Menopause},
  year={2005},
  volume={12},
  pages={497-511}
}
Objective: To create an evidence-based position statement regarding the role of exogenous testosterone in postmenopausal women. Design: The North American Menopause Society (NAMS) enlisted a panel of clinicians and researchers acknowledged to be experts in the field of testosterone therapy to review the evidence obtained from the medical literature, compile supporting statements and conclusions, and reach consensus on recommendations. The document was reviewed and approved by the NAMS Board of… 
Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society
TLDR
Current evidence supports the use of ET or EPT for menopause-related symptoms and disease prevention in appropriate populations of peri- and postmenopausal women.
The Endocrine Society Clinical Practice Guideline and The North American Menopause Society position statement on androgen therapy in women: another one of Yogi's forks.
  • G. Braunstein
  • Medicine
    The Journal of clinical endocrinology and metabolism
  • 2007
TLDR
Two committees composed of highly respected scientists diverging in an important clinical recommendation regarding treatment of women with testosterone are faced with a therapeutic dilemma resulting from the publication of two guidelines/position statements.
Testosterone therapy for sexual dysfunction in postmenopausal women
  • Z. Hubayter, J. Simon
  • Medicine, Biology
    Climacteric : the journal of the International Menopause Society
  • 2008
TLDR
Exogenous testosterone treatment provides a rational therapeutic alternative to consider in women whose hypoactive sexual desire disorder negatively affects their quality of life and who have no biologic or psychosocial causes not related to decreased androgen levels for their sexual disorder.
Testosterone replacement therapy in naturally and surgically menopausal women.
TLDR
The balance of evidence seems to show that androgens have more of a positive effect than a negative effect in women if used properly, and the majority of available data suggests that testosterone replacement in women can be used safely without increased risk of endometrial or breast cancer.
Testosterone therapy for postmenopausal decline in sexual desire: implications of a new study.
TLDR
The findings in the Davis et al article support the belief that, by avoiding first-pass liver effects of oral estrogens, in particular, an increase in SHBG, testosterone combined with transdermal estradiol results in more robust effects on sexual desire.
Androgen treatment in women
TLDR
Current evidence indicates that androgens have important biological effects in women, acting directly via androgen receptors in tissues, such as bone, skin fibroblasts, hair follicles and sebaceous glands, and indirectly via the aromatization of testosterone to estrogen on various sites.
The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
TLDR
Surgically menopausal women receiving testosterone experience significant increases in total satisfying sexual activity vs. women receiving placebo, significant improvement in all domains of sexual function, and decreases in personal distress, with a favorable safety profile.
Menopause and sexual desire: the role of testosterone
The present short review underlines the role of testosterone (T) in the motivational and satisfaction components of women's sexuality and critically discusses the strategies to treat hypoactive
Testosterone therapy in women with androgen deficiency: Its time has come.
  • A. Guay, A. Traish
  • Medicine, Biology
    Current opinion in investigational drugs
  • 2010
TLDR
Although more precise diagnostic techniques to measure total testosterone and free testosterone in women would be welcome, it is believed that physicians are able to identify women at risk of testosterone deficiency and safely replace these hormones in carefully selected patients.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 85 REFERENCES
Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause.
TLDR
It was clear that exogenous androgen enhanced the intensity of sexual desire and arousal and the frequency of sexual fantasies in hysterectomized and oophorectomization women, but there was no evidence that testosterone affected physiologic response or interpersonal aspects of sexual behavior.
Androgen levels in adult females: changes with age, menopause, and oophorectomy.
TLDR
It is reported that serum androgen levels decline steeply in the early reproductive years and do not vary because of natural menopause and that the postmenopausal ovary appears to be an ongoing site of testosterone production.
Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial.
Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status.
TLDR
It is concluded that serum sex steroid, FSH, and SHBG levels vary by ethnicity, but are highly confounded by ethnic disparities in body size.
Hormonal treatments of sexual unresponsiveness in postmenopausal women: a comparative study
TLDR
Although it is not possible to identify the reasons for change, the results indicate no advantages of supplementary testosterone administration over oestradiol alone for sexually unresponsive postmenopausal women.
Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women.
TLDR
In conclusion, E/A replacement therapy can improve body composition, lower-body muscle strength, quality of life, and sexual functioning in postmenopausal women.
Effects of estradiol with and without testosterone on body composition and relationships with lipids in postmenopausal women
TLDR
Addition of parenteral testosterone does not negate the favorable effects of estrogen on LDL cholesterol levels but may attenuate the reduction in centralized body fat achieved with E implants.
Testosterone effects on the breast: implications for testosterone therapy for women.
TLDR
Exogenous testosterone may serve as a natural endogenous protector of the breast and limit mitogenic and cancer-promoting effects of estrogen on mammary epithelium, and inclusion of testosterone in postmenopausal estrogen-progestin regimens has the potential to ameliorate the stimulating effects of combined estrogen- Progestin on the breast.
...
1
2
3
4
5
...